The correct answer is:
C) Colonoscopic surveillance every 1–3 years
This patient has long-standing extensive ulcerative colitis, which significantly increases the risk of colorectal cancer. The most important risk factors are the extent and duration of colonic inflammation. Patients with pancolitis begin to develop a substantially elevated cancer risk approximately 8–10 years after disease onset. This patient has extensive disease and has reached that threshold.
Unlike sporadic colorectal cancer, which usually develops through the conventional adenoma-carcinoma sequence, inflammatory bowel disease-associated colorectal cancer arises through chronic inflammation, repeated epithelial injury, and dysplasia. Because dysplastic lesions may be subtle, colonoscopic surveillance plays a central role in cancer prevention.
Current recommendations generally advise initiating surveillance colonoscopy approximately 8 years after diagnosis in patients with extensive ulcerative colitis or Crohn colitis, followed by surveillance every 1–3 years depending on risk factors and prior findings. Additional factors that increase risk include primary sclerosing cholangitis, family history of colorectal cancer, severe inflammation, and prior dysplasia.
A high-yield Step 2 distinction is that average-risk colorectal cancer screening recommendations do not apply to patients with long-standing inflammatory bowel disease. Their surveillance begins earlier and occurs more frequently because of their elevated cancer risk.
Answer choice A: Annual fecal immunochemical testing, is incorrect.
Fecal immunochemical testing (FIT) is designed for average-risk colorectal cancer screening. Patients with inflammatory bowel disease require direct endoscopic surveillance.
Answer choice B: Begin average-risk screening at age 45, is incorrect.
This recommendation applies to average-risk individuals. Long-standing ulcerative colitis substantially alters screening and surveillance requirements.
Answer choice D: Repeat colonoscopy in 10 years, is incorrect.
Ten-year intervals are appropriate after a normal screening colonoscopy in average-risk patients but are far too infrequent for patients with extensive ulcerative colitis.
Answer choice E: Surveillance is unnecessary while disease is controlled, is incorrect.
Cancer risk remains elevated despite symptomatic remission because risk is related to cumulative inflammatory exposure over time.
Key Learning Point
Patients with extensive ulcerative colitis or Crohn colitis should undergo surveillance colonoscopy beginning approximately 8 years after diagnosis and continuing every 1–3 years because of increased colorectal cancer risk.
